MedPath

Study of a Flu Vaccine in Children

Phase 3
Completed
Conditions
Influenza
Registration Number
NCT00001127
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

This study tests the safety and effectiveness of a flu vaccine in school children.

School children are usually the first members of a community to come down with the flu, and they often give the flu to their younger siblings, parents, and grandparents. It is hoped that giving school children a flu vaccine can help prevent the spread of the flu to other members of the community.

Detailed Description

This is a Phase III trial (an advanced study with a large number of patients). Your child will receive a single dose of flu vaccine, which is given by a nasal spray.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15000
Inclusion Criteria

Your child may be eligible for this study if he/she:

  • Is between the ages of 18 months and 18 years, with consent of parent or guardian.
  • Is a resident of the Temple-Belton, Texas area.
Read More
Exclusion Criteria

Your child will not be eligible for this study if he/she:

  • Has had a fever within 3 days before vaccination.
  • Has symptoms of a weakened immune system.
  • Has had a wheezing episode within the past 2 weeks.
  • Has moderate to severe asthma.
  • Is allergic to eggs.
  • Needs to take aspirin on a regular basis.
  • Has received another vaccine or study drug in the past month.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Pedro A. Piedra, M.D.

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath